Could a common cholesterol drug ease pancreatitis pain?
NCT ID NCT05771675
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This pilot study tests whether simvastatin, a common cholesterol medication, can improve quality of life in adults with recurrent acute or chronic pancreatitis. Researchers will enroll 90 participants to check if the drug is feasible and acceptable. The goal is to see if it helps with symptoms like pain and sleep, not to cure the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
Stanford University
RECRUITINGStanford, California, 94305, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
University of Southern California
RECRUITINGLos Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood and gut clues may flag pancreatic cancer risk early
- Can a lung drug tame the pain of chronic pancreatitis?
- Can a Decades-Old drug reverse pancreatic scarring?
- Can we predict who will develop pancreatic cancer from chronic pancreatitis?
- Brain scans reveal hidden pain pathways in chronic pancreatitis
- New device aims to make pancreatic and bile duct procedures safer